Related Experiment Video

Updated: Jul 9, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

The effect of altered Toll-like receptor 4 signaling on cancer cachexia

Trinitia Y Cannon1, Denis Guttridge, Jason Dahlman

  • 1Department of Otolaryngology, Head & Neck Surgery, G0412 Neurosciences Hospital, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7070, USA.

Archives of Otolaryngology--Head & Neck Surgery
|December 19, 2007
PubMed
Abstract

Insights

Mice with impaired Toll-like receptor (TLR) pathway signaling showed reduced cancer cachexia severity. This suggests that reduced inflammation may protect against cachexia, offering a new model for studying host contributions to the condition.

Area of Science:

  • Immunology
  • Oncology
  • Physiology

Background:

  • Cancer cachexia is a complex metabolic syndrome characterized by involuntary weight loss.
  • The role of inflammatory pathways, particularly Toll-like receptor (TLR) signaling, in cancer cachexia is not fully understood.

Purpose of the Study:

  • To investigate the impact of a defective Toll-like receptor (TLR) pathway on the development of cancer cachexia in a mouse model.
  • To determine if impaired inflammatory responses can mitigate the severity of cancer cachexia.

Main Methods:

  • A prospective animal study was conducted using female C3H/HeJ mice with a nonfunctional Toll-like receptor 4 (TLR4(d/d)) and wild-type C3H/HeN mice.
  • Mice were inoculated with SCCF-VII cells, and parameters including food intake, body weight, body composition, circulating cytokines (Interleukin-1beta), and muscle atrophy markers were analyzed.

Main Results:

  • TLR4(d/d) mice exhibited less severe cachexia, maintaining higher body weight and greater lean and fat mass compared to wild-type mice.
  • Wild-type mice had significantly elevated Interleukin-1beta levels, a key proinflammatory cytokine, whereas TLR4(d/d) mice did not.
  • Both groups showed evidence of muscle atrophy, but the overall cachectic phenotype was less pronounced in the TLR4-deficient mice.

Conclusions:

  • Impaired Toll-like receptor (TLR) pathway signaling, specifically the reduced secretion of proinflammatory cytokines like Interleukin-1beta, may confer protection against severe cancer cachexia.
  • This study establishes a novel animal model for further investigation into the host's role in the pathogenesis of cancer cachexia.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...